Antithrombotic Reversal Agents

Publication date: December 2017
Source:Hematology/Oncology Clinics of North America, Volume 31, Issue 6
Author(s): Matthew D. Wilson, Jonathan E. Davis

Teaser

The actively bleeding anticoagulated patient presenting to the emergency department requires rapid evaluation and treatment, which is made increasingly complicated by the ever-evolving antithrombotic treatment options used in medicine. Even with excellent supportive care, the timeliness with which reversal decisions need to be made continues to demand of the emergency practitioner a familiarity with the properties and general characteristics of a variety of antithrombotic agents. Reversal options vary and may include vitamin K, FFP, PCC, rFVIIa, platelets, and desmopressin, among others.


http://ift.tt/2z9wZMd